Zymes Funds Postdoctoral Fellow at University of California
November 17, 2006
Zymes is pleased to annound the appointment of Subir Ghorai, Ph.D. as the Zymes Postdoctoral Fellow at the University of California’s Department of Chemistry in Santa Barbara.
Dr. Ghorai will focus on the development of a “second generation” delivery system to complement Zymes’ existing water-solubilizing technology, UbiSol-Aqua™. UbiSol-Aqua™ uses nanotechnology and complexation to better solubilize and reformulate drug, nutrient and cosmetic ingredients.
“The implications of HQO™, UbiSol-Aqua™ and related delivery system technologies to the human body are astounding” said Dr. Lipshutz, Co-founder and Executive Vice President of Research and Development at Zymes. “We are committed to ensuring that research continues to fuel advancements that will allow people to harness these powerful benefits.”
Dr. Ghorai received a Ph.D. in chemistry from the Indian Institute of Chemical Biology and will play an important role in helping Zymes further its mission to develop high quality products that provide significant health and beauty benefits to consumers. He has an impressive background in conducting breakthrough research.
About Zymes
Zymes, LLC is a bio-science company that combines science, technology and nature to create products that improve the quality of life. It is dedicated to contributing to the well-being of individuals by developing high-quality products that provide significant, clinically-proven health and beauty benefits to consumers. Based in Hasbrouck Heights, NJ, Zymes holds substantial intellectual property ranging from production of synthetic coenzyme Q10 to pharmaceutical drug delivery systems.
